Shilpa Biologicals Profile
Key Indicators
- Authorised Capital ₹ 60.00 Cr
- Paid Up Capital ₹ 56.28 Cr
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 452.16 Cr
- Satisfied Charges ₹ 350.00 Cr
- Revenue Growth 59.63%
- Profit Growth -165.41%
- Ebitda -64.72%
- Net Worth -242.42%
- Total Assets -3.63%
About Shilpa Biologicals
Shilpa Biologicals Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 January 2020 (Five years and one month 13 days old ). Its registered office is in Dharwad, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 60.00 Cr and a paid-up capital of Rs 56.28 Cr.
The company currently has active open charges totaling ₹452.16 Cr. The company has closed loans amounting to ₹350.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Shilpa Biologicals Private Limited India are Anushiya Bhandari as Company Secretary, Sridevi Khambhampaty as Ceo, and Venkatesh Sharma as Cfo. Vishnukanth Bhutada, Ramakant Innani, and Madhav Bhutada serve as directors at the Company.
Company Details
- Location
Dharwad, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230KA2020PTC131456
- Company No.
131456
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jan 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Shilpa Biologicals?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramakant Innani  | Managing Director | 09-Jan-2020 | Current |
| Anushiya Bhandari | Company Secretary | 09-Oct-2024 | Current |
| Sridevi Khambhampaty | CEO | 24-Oct-2024 | Current |
| Venkatesh Sharma | CFO | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishnukanth Bhutada | Nominee Director | 09-Jan-2020 | Current |
| Madhav Bhutada | Director | 10-Aug-2022 | Current |
Financial Performance of Shilpa Biologicals.
Shilpa Biologicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59.63% increase. The company also saw a substantial fall in profitability, with a 165.41% decrease in profit. The company's net worth observed a substantial decline by a decrease of 242.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shilpa Biologicals?
In 2023, Shilpa Biologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sravathi Advance Process Technologies Private LimitedVishnukanth Bhutada and Ramakant Innani are mutual person
Inm Technologies Private LimitedVishnukanth Bhutada and Ramakant Innani are mutual person
Inm Nuvent Paints Private LimitedVishnukanth Bhutada and Ramakant Innani are mutual person
Ftf Pharma Private LimitedVishnukanth Bhutada is a mutual person
Shilpa Medicare LimitedVishnukanth Bhutada is a mutual person
- Shilpa Pharma Lifesciences Limited
Vishnukanth Bhutada and Ramakant Innani are mutual person
Charges (Loans)
₹452.16 Cr
₹350.00 Cr
Charges Breakdown by Lending Institutions
- Others : 452.16 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Aug 2023 | Others | ₹450.00 Cr | Open |
| 20 Jul 2021 | Others | ₹2.16 Cr | Open |
| 10 Feb 2022 | Hdfc Bank Limited | ₹100.00 Cr | Satisfied |
| 10 Aug 2020 | Hdfc Bank Limited | ₹250.00 Cr | Satisfied |
How Many Employees Work at Shilpa Biologicals?
Shilpa Biologicals has a workforce of 240 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shilpa Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shilpa Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
